Enwei Pharmaceutical Co (SZSE:301331) Days Sales Outstanding : 47.47 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Enwei Pharmaceutical Co Days Sales Outstanding?

Enwei Pharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥95.4 Mil. Enwei Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥183.5 Mil. Hence, Enwei Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 47.47.

The historical rank and industry rank for Enwei Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SZSE:301331' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.14 Med: 41.97 Max: 47.85
Current: 47.85

During the past 7 years, Enwei Pharmaceutical Co's highest Days Sales Outstanding was 47.85. The lowest was 31.14. And the median was 41.97.

SZSE:301331's Days Sales Outstanding is ranked better than
73.37% of 999 companies
in the Drug Manufacturers industry
Industry Median: 71.7 vs SZSE:301331: 47.85

Enwei Pharmaceutical Co's Days Sales Outstanding stayed the same from Mar. 2023 (47.47) to Mar. 2024 (47.47).

Enwei Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Enwei Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enwei Pharmaceutical Co Days Sales Outstanding Chart

Enwei Pharmaceutical Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

41.97

47.29

39.53

45.65

44.49

Enwei Pharmaceutical Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial														47.47	49.08	52.74	41.61	47.47

Competitive Comparison of Enwei Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Enwei Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enwei Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enwei Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Enwei Pharmaceutical Co's Days Sales Outstanding falls into.

Enwei Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Enwei Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (98.331	+	93.096)	/	2 )	/	785.191	*	365
=	95.7135					/	785.191	*	365
=	44.49

Enwei Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (93.096	+	97.802)	/	2 )	/	183.476	*	365 / 4
=	95.449					/	183.476	*	365 / 4
=	47.47

Enwei Pharmaceutical Co (SZSE:301331) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Enwei Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Enwei Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Enwei Pharmaceutical Co (SZSE:301331) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enwei Pharmaceutical Co Ltd (SZSE:301331) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

Chuangye Avenue, Enwei Building, Economic Development Zone, Aba District, Tibet Autonomous Region, Changdu, CHN, 854000

Website

http://www.enwei.com.cn

Enwei Pharmaceutical Co Ltd is engaged in the research and development, production and sales of proprietary Chinese medicines and chemical medicines.

Enwei Pharmaceutical Co (SZSE:301331) Headlines

No Headlines